BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 26215394)

  • 1. Attenuated Semliki Forest virus for cancer treatment in dogs: safety assessment in two laboratory Beagles.
    Autio KP; Ruotsalainen JJ; Anttila MO; Niittykoski M; Waris M; Hemminki A; Vähä-Koskela MJ; Hinkkanen AE
    BMC Vet Res; 2015 Jul; 11():170. PubMed ID: 26215394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic capacity of attenuated replicative semliki forest virus in human melanoma xenografts in severe combined immunodeficient mice.
    Vähä-Koskela MJ; Kallio JP; Jansson LC; Heikkilä JE; Zakhartchenko VA; Kallajoki MA; Kähäri VM; Hinkkanen AE
    Cancer Res; 2006 Jul; 66(14):7185-94. PubMed ID: 16849565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Semliki forest virus vector as a novel candidate against unresectable osteosarcoma.
    Ketola A; Hinkkanen A; Yongabi F; Furu P; Määttä AM; Liimatainen T; Pirinen R; Björn M; Hakkarainen T; Mäkinen K; Wahlfors J; Pellinen R
    Cancer Res; 2008 Oct; 68(20):8342-50. PubMed ID: 18922906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cancer virotherapy with attenuated replicative Semliki forest virus in different rodent tumor models.
    Määttä AM; Liimatainen T; Wahlfors T; Wirth T; Vähä-Koskela M; Jansson L; Valonen P; Häkkinen K; Rautsi O; Pellinen R; Mäkinen K; Hakumäki J; Hinkkanen A; Wahlfors J
    Int J Cancer; 2007 Aug; 121(4):863-70. PubMed ID: 17443493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication competent Semliki Forest virus prolongs survival in experimental lung cancer.
    Määttä AM; Mäkinen K; Ketola A; Liimatainen T; Yongabi FN; Vähä-Koskela M; Pirinen R; Rautsi O; Pellinen R; Hinkkanen A; Wahlfors J
    Int J Cancer; 2008 Oct; 123(7):1704-11. PubMed ID: 18651570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
    Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
    J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenously administered alphavirus vector VA7 eradicates orthotopic human glioma xenografts in nude mice.
    Heikkilä JE; Vähä-Koskela MJ; Ruotsalainen JJ; Martikainen MW; Stanford MM; McCart JA; Bell JC; Hinkkanen AE
    PLoS One; 2010 Jan; 5(1):e8603. PubMed ID: 20066051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.
    Vähä-Koskela MJ; Tuittila MT; Nygårdas PT; Nyman JK; Ehrengruber MU; Renggli M; Hinkkanen AE
    J Neurovirol; 2003 Feb; 9(1):1-15. PubMed ID: 12587064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncolytic alphavirus SFV-VA7 efficiently eradicates subcutaneous and orthotopic human prostate tumours in mice.
    Martikainen M; Ruotsalainen J; Tuomela J; Härkönen P; Essand M; Heikkilä J; Hinkkanen A
    Br J Cancer; 2017 Jun; 117(1):51-55. PubMed ID: 28557974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner.
    Ehrengruber MU; Renggli M; Raineteau O; Hennou S; Vähä-Koskela MJ; Hinkkanen AE; Lundstrom K
    J Neurovirol; 2003 Feb; 9(1):16-28. PubMed ID: 12587065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncolytic reovirus therapy: Pilot study in dogs with spontaneously occurring tumours.
    Hwang CC; Igase M; Sakurai M; Haraguchi T; Tani K; Itamoto K; Shimokawa T; Nakaichi M; Nemoto Y; Noguchi S; Coffey M; Okuda M; Mizuno T
    Vet Comp Oncol; 2018 Jun; 16(2):229-238. PubMed ID: 29076241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-tumour activity of oncolytic Western Reserve vaccinia viruses in canine tumour cell lines, xenografts, and fresh tumour biopsies.
    Autio K; Knuuttila A; Kipar A; Ahonen M; Parviainen S; Diaconu I; Kanerva A; Hakonen T; Vähä-Koskela M; Hemminki A
    Vet Comp Oncol; 2016 Dec; 14(4):395-408. PubMed ID: 25302859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain.
    van den Pol AN; Mao G; Chattopadhyay A; Rose JK; Davis JN
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28077641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
    Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
    J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication of the A7(74) strain of Semliki Forest virus is restricted in neurons.
    Fazakerley JK; Pathak S; Scallan M; Amor S; Dyson H
    Virology; 1993 Aug; 195(2):627-37. PubMed ID: 8393239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safe and Effective Treatment of Experimental Neuroblastoma and Glioblastoma Using Systemically Delivered Triple MicroRNA-Detargeted Oncolytic Semliki Forest Virus.
    Ramachandran M; Yu D; Dyczynski M; Baskaran S; Zhang L; Lulla A; Lulla V; Saul S; Nelander S; Dimberg A; Merits A; Leja-Jarblad J; Essand M
    Clin Cancer Res; 2017 Mar; 23(6):1519-1530. PubMed ID: 27637889
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of immune responses in protection and pathogenesis during Semliki Forest virus encephalitis.
    Amor S; Scallan MF; Morris MM; Dyson H; Fazakerley JK
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():281-91. PubMed ID: 8627232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety studies and viral shedding of intramuscular administration of oncolytic vaccinia virus TG6002 in healthy beagle dogs.
    Béguin J; Nourtier V; Gantzer M; Cochin S; Foloppe J; Balloul JM; Laloy E; Tierny D; Klonjkowski B; Quemeneur E; Maurey C; Erbs P
    BMC Vet Res; 2020 Aug; 16(1):307. PubMed ID: 32843040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins.
    Landis H; Simon-Jödicke A; Klöti A; Di Paolo C; Schnorr JJ; Schneider-Schaulies S; Hefti HP; Pavlovic J
    J Virol; 1998 Feb; 72(2):1516-22. PubMed ID: 9445055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncolytic effects of reovirus in canine solid tumor cell lines.
    Igase M; Hwang CC; Coffey M; Okuda M; Noguchi S; Mizuno T
    J Vet Med Sci; 2015 May; 77(5):541-8. PubMed ID: 25648933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.